Schlagwort: Heidelberg Capital Private Equity
vasopharm announces 20 Mio. EUR fundraising
vasopharm GmbH from Würzburg, a privately held biopharmaceutical company focusing on novel therapeutics for the treatment of cerebrovascular diseases, announced a successfully raised 20 Mio. EUR of new capital.